Abbott(ABT) - 2025 Q3 - Earnings Call Presentation

THIRD-QUARTER 2025 RESULTS $5.4B MEDICAL DEVICES $1.5B ESTABLISHED $2.2B NUTRITION $5.12 to $5.183 REAFFIRMED FULL-YEAR GUIDANCE TOTAL COMPANY SALES $11.4B +7.5%1 Organic* sales growth for underlying base business** ADJUSTED DILUTED EPS $1.302 KEY BUSINESS UNITS ADJUSTED DILUTED EPS Narrowed range reflects double-digit growth at the midpoint 7.5% to 8.0%3 ORGANIC SALES GROWTH Excluding COVID-19 testing-related sales BUSINESS HIGHLIGHTS EXPANDING ALTERNATIVES TO OPEN-HEART SURGERY EXTENDING GLOBAL REACH OF S ...